HGH 176-191 is a "functional subset extract" of the carboxyl terminus of human growth hormone, representing a quantum precision revolution in metabolic therapy. It does not provide the complete hormone signal; instead, it precisely severs the lipolytic topology of growth hormone, selectively activating the "lipolytic dimer" conformation of the GHR receptor in adipocytes. Like a molecular-level scalpel, it initiates the spatiotemporal waves of decomposition only in adipose tissue, simultaneously optimizing fatty acid release sequences and oxidation channels, achieving "fat programming" rather than systemic metabolic interference.
|
Name |
HGH 176-191 |
|
Appearance |
White freeze-dried powder |
|
Purity |
99%+ |
|
Minimum order |
10vials/kit |
|
Estate/Nation |
Shenzhen, China |
|
Accepted payment methods |
BTC/USDT/Bank Transfer/Western Union |
|
Transportation time |
Around 10-15days |
Content
HGH 176/191: A "Precision Sniper" in Fat Metabolism

HGH 176/191 is not a "multi-functional" growth hormone in the traditional sense; it's more like a genetically edited "fat metabolism assassin." As a truncated fragment of the C-terminus of human growth hormone (HGH) from amino acids 176 to 191, it eliminates the "rough" parts responsible for bone growth, organ hypertrophy, and blood sugar fluctuations, retaining only the "refined" instructions specifically targeting fat cells. This molecular-level "refinement" makes it a "special forces" unit in the field of fat loss, launching precise attacks on stubborn fat without disturbing the body's growth system.
Mechanism of Action
A "Dual-Track Blockade" of Lipolysis and Anti-Lipogene Formation
The mechanism of action of HGH 176/191 is not a simple "burning," but a precise "metabolic reprogramming." It primarily reshapes the body's energy landscape through two pathways: A "Lipolysis Accelerator": HGH 176/191 mimics the lipolytic activity of intact growth hormone, acting directly on receptors on the surface of adipocytes to activate hormone-sensitive lipase (HSL). This process acts like opening the "gates" to fat stores, causing triglycerides to break down into free fatty acids, which are released into the bloodstream for use as energy in muscles and other tissues. Studies have shown that its lipolysis efficiency is even superior to intact growth hormone under certain conditions because it can more effectively mobilize fat reserves without being distracted by other physiological functions.
In addition to "opening up new sources" (breaking down fat), HGH 176/191 also possesses the unique ability to "restrict" (inhibit fat synthesis). It inhibits the activity of lipoprotein lipase (LPL), an enzyme normally responsible for transporting fat from the blood and storing it in adipocytes. By blocking this process, HGH 176/191 not only consumes existing fat but also prevents the accumulation of new fat, creating a "nothing in, only out" metabolic negative pressure, which is particularly crucial for combating stubborn abdominal fat. Metabolic Specificity: Avoiding the "Danger Zone" of Blood Sugar and Growth.
Unlike traditional HGH, HGH 176/191 undergoes a key structural change, causing it to lose its ability to bind extensively to insulin and growth hormone receptors. This means it does not cause side effects such as elevated blood sugar, insulin resistance, or acromegaly. Like an "invisible man," it moves through the metabolic system, interacting only with the fat metabolism pathway, achieving the ideal state of "fat reduction without muscle loss, fat burning without blood sugar spikes." This high specificity makes it a "safe option" for those who want to improve their body composition but fear the side effects of hormones.
Spatial and Temporal Limitations: Relying on Exercise-Based "Conditional Triggers"
HGH 176/191 is not a "slimming" drug; its mechanism of action is highly dependent on the user's behavior. If the free fatty acids it releases are not consumed promptly through aerobic exercise, they will flow back into fat cells, and may even temporarily affect insulin sensitivity due to excessively high blood fatty acid concentrations. Therefore, it is more like an "opportunity creator," creating a window of opportunity for fat burning through injection, while the actual "burning" must be accomplished through exercise. This strong "drug + behavior" binding mechanism means it's only suitable for highly disciplined trainees who are hitting a weight loss plateau, rather than the first choice for ordinary obese individuals.
In summary, HGH 176/191, with its "de-growth and lipolysis" molecular design, has pioneered a new "precision strike" path in the field of weight loss. Through a dual-track mechanism of accelerating lipolysis and inhibiting lipogenesis, it efficiently reshapes body composition without interfering with blood sugar and growth. However, its highly conditional effects (dependent on fasting and exercise) and potential insulin sensitivity risks require users to possess extremely high self-discipline and a scientifically planned cycle to maximize its "targeting" potential.
Hot Tags: hgh 176/191(fragment), China hgh 176/191(fragment) manufacturers, suppliers











